Off-label use for hyperbilirubinemia: Phenobarbital induces glucuronyl transferase and hepatic bilirubin-binding Y-protein to reduced serum bilirubin concentrationsAvoid; coadministration with CYP3A inducers may perhaps cause lessened plasma concentrations of elvitegravir and/or a concomitantly administered protease inhibitor and result in loss of